• Biochemical assay development for high throughput screening of new molecules for anti-tubercular activity. 
  • Enzyme purification and active site characterization, interaction with inhibitors.
  • Application of Chemoinformatics and Molecular modeling tools for understanding structure-biological activity relationship and its application in drug design (Target-based/ligand-based drug design)
  • Study of infection mechanisms of Mycobacteria and related Biochemical studies.
  • Biochemical, proteomic and molecular biological characterization of signaling cascades
  • Target identification and validation of novel inhibitors